CATALOGO DEI PRODOTTI DELLA RICERCA

IDOLAZZI, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.717
NA - Nord America 4.408
AS - Asia 1.507
SA - Sud America 21
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 8
AF - Africa 7
Totale 10.677
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.391
GB - Regno Unito 2.027
CN - Cina 1.361
DE - Germania 503
IT - Italia 488
SE - Svezia 471
IE - Irlanda 388
FR - Francia 380
FI - Finlandia 228
UA - Ucraina 73
TR - Turchia 65
RU - Federazione Russa 62
BE - Belgio 27
VN - Vietnam 24
NL - Olanda 16
CA - Canada 15
KR - Corea 15
RO - Romania 15
AT - Austria 12
BR - Brasile 12
IR - Iran 11
JP - Giappone 8
IN - India 6
AU - Australia 5
QA - Qatar 5
A2 - ???statistics.table.value.countryCode.A2??? 4
CH - Svizzera 4
EG - Egitto 4
EU - Europa 4
HK - Hong Kong 4
CL - Cile 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PL - Polonia 3
SK - Slovacchia (Repubblica Slovacca) 3
AR - Argentina 2
BG - Bulgaria 2
CZ - Repubblica Ceca 2
ES - Italia 2
SA - Arabia Saudita 2
SI - Slovenia 2
ZA - Sudafrica 2
A1 - Anonimo 1
BD - Bangladesh 1
BO - Bolivia 1
CU - Cuba 1
EC - Ecuador 1
FK - Isole Falkland (Malvinas) 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
IQ - Iraq 1
IS - Islanda 1
LV - Lettonia 1
MA - Marocco 1
MK - Macedonia 1
MN - Mongolia 1
MX - Messico 1
PE - Perù 1
SG - Singapore 1
UZ - Uzbekistan 1
Totale 10.677
Salva come PNG Salva come JPEG
Città #
Southend 1.927
Chandler 956
Jacksonville 469
Woodbridge 390
Dublin 387
Ann Arbor 315
Ashburn 276
Beijing 229
Houston 205
Lawrence 161
Princeton 161
Wilmington 155
Jinan 144
Redmond 128
Shenyang 126
Bologna 124
Nanjing 120
Helsinki 84
Verona 84
New York 83
Hebei 73
Tianjin 63
Zhengzhou 52
Changsha 51
Haikou 51
Ningbo 51
Sindelfingen 44
Taizhou 41
Nanchang 38
Taiyuan 38
Redwood City 34
Milan 33
Hangzhou 31
Jiaxing 31
Norwalk 25
Brussels 24
Guangzhou 24
Lanzhou 24
Fuzhou 23
Washington 22
Düsseldorf 21
Seattle 20
Dearborn 19
Sanayi 18
Lancaster 16
Boardman 15
Falls Church 15
Nürnberg 15
Orani 15
Fairfield 13
San Francisco 13
Detroit 12
Dong Ket 11
Venice 11
Vienna 11
Toronto 10
Chicago 9
Esslingen am Neckar 9
Florianópolis 8
Bârlad 7
Dongguan 7
Rome 7
Seoul 7
Cagliari 6
Clearwater 6
Kemerovo 6
Seo-gu 6
Auburn Hills 5
Turin 5
Central 4
Easton 4
Renton 4
Riva 4
Shanghai 4
Zanjan 4
Ardabil 3
Biandronno 3
Brescia 3
Frankfurt am Main 3
Genova 3
London 3
Los Angeles 3
Luino 3
Novokuznetsk 3
Phoenix 3
San Mateo 3
Tappahannock 3
Tarcento 3
Tokyo 3
Trieste 3
Udine 3
Xiangfen 3
Acquaviva Picena 2
Adliswil 2
Alghero 2
Amsterdam 2
Atlanta 2
Augusta 2
Bratislava 2
Cambridge 2
Totale 7.711
Salva come PNG Salva come JPEG
Nome #
Teriparatide and denosumab combination therapy and skeletal metabolism 240
Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab 143
Long-term effects of amino-bisphosphonates on circulating gamma-delta T cells 125
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 123
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 115
Longitudinal Evaluation of Bone Mineral Density and Bone Metabolism Markers in Patients with Indolent Systemic Mastocytosis Without Osteoporosis 112
Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone 110
CD14(++) CD16(-) monocytes are the main source of 11β-HSD type 1 after IL-4 stimulation 109
Prevalence and incidence of rheumatoid arthritis in Italy. 106
Bone metabolism in patients with anorexia nervosa and amenorrhoea 106
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 105
DXA bone mineral density in males: retrospective study in real life. 104
Bone mineral density and bone turnover in premenopausal women with rheumatoid arthritis 104
Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis 104
Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial 103
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial 103
Prednisone compared to methysprednisolone in the polymyalgia rheumatica treatment 101
Osteopetrosi 98
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 98
New strategies for the prevention and treatment of systemic and local bone loss; from pathophysiology to clinical application 98
Vitamin D levels in patients with psoriasis with or without arthritis 96
Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin. 95
Concentric left ventricular remodelling is associated with subclinical systolic dysfunction in patients with psoriatic arthritis 95
Sclerostin and DKK1 in postmenopausal osteoporosis treated with Denosumab. 95
Dose-dependent short-term effects of single high doses of oral vitamin D3 on bone turnover markers 94
Denosumab, cortical bone and bone erosions in rheumatoid arthritis 94
Prevalence of osteoporosis in patients affected by mastocytosis 93
Denosumab for the Treatment of Mastocytosis-Related Osteoporosis: A Case Series 93
Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I. 91
Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis 91
Could γ\δ T-cells explain zoledronic acid adverse events? 89
AB0776 18F-Fluoride PET/CT for Detection of Axial Involvement in Ankylosing Spondylitis: 88
MEDAL con etoricoxib: l’inizio di una nuova era per il trattamento del dolore muscolo scheletrico 86
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 86
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 86
Bisphosphonates vs infliximab in ankylosing spondylitis treatment. 85
Drug-induced osteonecrosis of the jaw: the state of the art 85
Suboptimal methotrexate use in rheumatoid arthritis patients in Italy: the MARI study 83
Vitamin D levels strongly influence bone mineral density and bone turnover markers during weight gain in female patients with anorexia nervosa 83
Periostin: The bone and beyond 83
Previous use of amino-bisphosphonates and circulating gamma/delta T cells 82
Long-term consequences of a treatment course with bisphosphonates in primary hyperparathyroidism 81
Short-Term Effects of TNF Inhibitors on Bone Turnover Markers and Bone Mineral Density in Rheumatoid Arthritis 81
Titer-Dependent Effect of Anti-Citrullinated Protein Antibodies On Systemic Bone Mass in Rheumatoid Arthritis Patients 81
Strong relationship between vitamin D status and bone mineral density in anorexia nervosa 81
Short-term effects on bone turnover markers of a single high dose of oral vitamin D₃. 80
Bone involvement in patient with clonal mast cell disorders 80
Bone involvement and osteoporosis in mastocytosis. 80
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study 80
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 80
Osteoporosi ed attività sportiva. 79
Treatment of complex regional pain syndrome type I with neridronate: a randomized, double-blind, placebo-controlled study. 79
Duration of treatment for osteoporosis 79
Effects of denosumab on peripheral lymphocyte subpopulations 79
Improvements in the management of rheumatic patients from vertebral imagee obtained through dual-energy X-ray absorptiometry. 78
Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes 78
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 78
Sclerostin and DKK1 in primary hyperparathyroidism. 77
Vitamin D and rheumatic diseases. 77
Variazione della densità minerale ossea ed attività antifratturativa; 77
Rheumatoid arthritis, γδ T cells and bisphosphonates 76
Osteoporosi ed attività sportiva: 75
In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls 74
Relationship between serum parathyroid hormone, vitamin D sufficiency, age, and calcium intake. 73
A case of mandible Paget’s disease of the bone treated with intravenous neridronate 73
Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 73
Marked increases in bone mineral density and biochemical markers of bone turnover in patients with anorexia nervosa gaining weight 72
Neridronic acid for the treatment of bone metabolic diseases 72
Seasonal and regional variations in the prevalence of vitamin D insufficiency in patiens with theumatoid arthritis 72
Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis 72
The obesity paradox and osteoporosis 72
Ruolo della vitamina D 71
Factors associated with accelerated subclinical atherosclerosis in patients with spondyloarthritis without overt cardiovascular disease 71
Zoledronic Acid in Osteoporosis Secondary to Mastocytosis. 70
The waning of teriparatide effect on bone formation markers in postmenopausal osteoporosis is associated with increasing serum levels of DKK1 69
Disease activity and left ventricular systolic function in rheumatoid arthritis 68
Challenge of diagnosing ANCA-associated vasculitis during COVID-19 pandemic: a missed 'window of opportunity' 68
Variazione della densità minerale ossea ed attività antifratturativa. 67
Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis. 67
Focal bone involvement in inflammatory arthritis: the role of IL17 67
Effects of secukinumab on serum adipocytokines: preliminary data 67
Quantitative chest computed tomography is associated with two prediction models of mortality in interstitial lung disease related to systemic sclerosis 67
Operator-independent quantitative chest computed tomography versus standard assessment of interstitial lung disease related to systemic sclerosis: A multi-centric study 67
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells 66
Clinical development of neridronate: potential for new applications. 65
Vitamin D: not just bone, but also immunity 64
Inhibition of tumor necrosis factor-alpha (TNF-alpha) in patients with early rheumatoid arthritis results in acute changes of bone modulators 64
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 64
Anti-TNF treatment response in rheumatoid arthritis patients with moderate disease activity: a prospective observational multicentre study (MODERATE) 62
Vitamin D status in patients with chronic plaque psoriasis 61
Ultrasonography of the nail unit reveals quantitative and qualitative alterations in patients with psoriasis and psoriatic arthritis 61
Correction to: The ultrasonographic study of the nail reveals differences in patients affected by inflammatory and degenerative conditions 61
Disease Activity and Anticitrullinated Peptide Antibody Positivity Predict the Worsening of Ventricular Function in Rheumatoid Arthritis 61
Development and First Validation of a Disease Activity Score for Gout 60
18F-fluoride PET/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity 60
Rational and results of weekly treatment with calcidiol in postmenopausal and senile osteoporosis 59
Insight into the WNT system and its drug related response. 59
Vitamin D and fractures: a systematic review 58
Could nail and joint alterations make the difference between psoriatic arthritis and osteoarthritis during the ultrasonographic evaluation of the distal interphalangeal joints? 58
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases 58
Totale 8.349
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.807
article - articoli 33.362
book - libri 0
conference - conferenze 267
curatela - curatele 0
other - altro 178
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.614
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201945 0 0 0 0 0 0 0 0 0 12 7 26
2019/20201.350 194 26 26 138 153 141 152 86 95 98 79 162
2020/20211.377 188 285 40 255 182 122 20 43 81 11 107 43
2021/20221.208 93 347 7 62 54 29 24 65 81 24 85 337
2022/20232.716 192 292 244 501 215 654 45 145 295 30 76 27
2023/2024989 54 115 109 153 159 184 61 126 6 22 0 0
Totale 10.990